The most commonly reported adverse reactions were nausea, weakness, fever/chills, vomiting, headache, diarrhea, and dizziness.
Very common (10% or more): Hypertension (24%)Uncommon (0.1% to 1%): Hypotension (0.25%), hot flushRare (less than 0.1%): Myocardial infarction, induced Adam-Stokes syndrome, superficial thrombophlebitis Postmarketing reports: Syncope, fainting, loss of consciousness, hypotension (including orthostatic), light-headedness, tachycardia (including racing pulse, heart palpitations, heart pounding)
Very common (10% or more): Thyroid function test abnormal (18%) in patients with Cushing syndrome
It was reported that of the 42 Cushing syndrome patients with detectable TSH at baseline, eight (19%) had increases in TSH above the normal range, while remaining asymptomatic.  The TSH levels returned to normal in most patients when this drug was discontinued at the end of the study.Adrenal insufficiency was reported in two subjects (4%) in Study 400.  The most typical symptoms of adrenal insufficiency were nausea and decreased appetite.  Adrenal insufficiency resolved in both cases with interruption of this drug and/or dexamethasone administration.
Very common (10% or more): Nausea (48%), vomiting (26%), dry mouth (18%), diarrhea (12%), constipation (10%), gastric discomfort, abdominal painCommon (1% to 10%): Light or moderate cramping Rare (less than 0.1%): Gastric bleeding, necrotising pancreatitisPostmarketing reports: Dyspepsia, gastroesophageal reflux
Heavy bleeding occurs in about 5% of the cases and may require hemostatic curettage in up to 1.4% of the cases.In clinical trials surgical evacuation was needed in 10% to 12% of women, with some studies reporting a rate as high as 20% to 30%.  Bleeding can be prolonged for several days after prostaglandin analog administration and sometimes leads to a decrease in hemoglobin levels.
Very common (10% or more): Uterine contractions or cramping (up to 45%) following prostaglandin intake, endometrial hypertrophy (38%), vaginal bleeding, uterine spasmCommon (1% to 10%): Endometritis, pelvic inflammatory disease, heavy uterine bleeding, prolonged post abortion bleeding, spotting, severe hemorrhage, breast tendernessUncommon (0.1% to 1%): Uterine rupture after prostaglandin intake (during induction of second trimester termination of pregnancy or labor induction for fetal death in utero during the third trimester), hemorrhagic shock, salpingitisRare (less than 0.1%): Hydatiform mole, ectopic pregnancy, amniotic band syndrome, gestational trophoblastic tumor, uteroplacental apoplexy, bilateral adnexal mass, intrauterine adhesion, ovarian cyst rupture, breast abscess, hematosalpinx, uterine rupturePostmarketing reports: Post-abortal infection (including endometritis, endomyometritis, parametritis, pelvic infection, pelvic inflammatory disease, salpingitis); hematometra, leukorrhea, vaginal hemorrhage, metrorrhagia
Very common (10% or more): Blood potassium decreased (34%) in Cushing syndrome patientsRare (less than 0.1%): Thrombotic thrombocytopenic purpura, thrombocytopenia, induced systemic lupus erythematosusPostmarketing reports: Anemia
In Cushing syndrome patients:Very common (10% or more): Decreased appetite (20%), anorexia (10%) Postmarketing reports: Increased triglycerides, hypoglycemia
Very common (10% or more): Arthralgia (30%), back pain (16%), myalgia (14%), pain in the extremity (12%)Rare (less than 0.1%): Limb spasmPostmarketing reports: Muscular weakness, flank pain, musculoskeletal chest pain
Very common (10% or more): Headache (44%), dizziness (22%), somnolence (10%)Rare (less than 0.1%): Vagal symptoms (hot flushes, dizziness, chills), epilepsy, neurogenic tinnitus
Very common (10% or more): Fatigue (48%), peripheral edema (26%), pain (14%), chill, feverCommon (1% to 10%): FaintingRare (0.01% to 0.1%): MalaiseVery rare (less than 0.01%): Fatal toxic shock caused by Clostridium sordellii endometritis or Escherichia coli (use of mifepristone followed by non authorized vaginal administration of misoprostol oral tablets)Postmarketing reports: Asthenia, edema, pitting edema, thirst
Very common (10% or more): Anxiety (10%)Rare (less than 0.1%): ManiaPostmarketing reports: Insomnia
Very common (10% or more): Dyspnea (16%), sinusitis (14%), nasopharyngitis (12%)Rare (less than 0.1%): Bronchospasm, induced bronchial asthmaFrequency not reported: Shortness of breath
Uncommon (0.1% to 1%): Skin rashes (0.2%), pruritusRare (0.01% to 0.1%): Urticaria, erythroderma, erythema nodosum, toxic epidermal necrolysis	Very rare (less than 0.01%): Angioedema
Rare (less than 0.1%): Abnormal liver function tests, hepatic failure, hepatorenal failure
Rare (less than 0.1%): AnaphylaxisPostmarketing reports: Allergic reaction (including anaphylaxis, angioedema, hives, rash, itching)
Rare (less than 0.1%): Ophthalmoplegia, periorbital edema
Rare (less than 0.1%): Elevated alpha-feto protein, elevated carcinoembryonic antigen
Rare (less than 0.1%): Renal failure
Excessively heavy vaginal bleeding
unusual tiredness or weakness
Chest pain or discomfort
confusion
cough or hoarseness
fast, weak pulse
fever or chills
lower back or side pain
pain or discomfort in the arms, jaw, back, or neck
painful or difficult urination
pale, cold, or clammy skin
shortness of breath
sudden increase in stomach or shoulder pain
sweating
unusual or large amount of vaginal bleeding
Abdominal or stomach pain or uterine cramping
back pain
diarrhea
dizziness
headache
nausea or vomiting
Acid or sour stomach
anxiety
belching 
cough
fainting or lightheadedness when getting up from a lying or sitting position
fever
flu-like symptoms
headache
heartburn
increased clear or white vaginal discharge
indigestion
itching of the vagina or genital area
lack or loss of strength
pain during sexual intercourse
pain or tenderness around the eyes and cheekbones
pale skin
shaking chills
stomach discomfort, upset, or pain
stuffy or runny nose
tightness of the chest
trouble sleeping
troubled breathing
troubled breathing, exertional
unusual bleeding or bruising